2-Phenyl-2-methyl-hexafluor-propan | 16204-44-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Phenyl-2-methyl-hexafluor-propan
• 英文别名: (1,1,1,3,3,3-Hexafluoro-2-methylpropan-2-yl)benzene
• CAS: 16204-44-7
• 化学式: C₁₀H₈F₆
• 分子量: 242.164
• InChiKey: NAWRKOHYUOCWLG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  2-苯基五氟丙烯 、 碘甲烷 在 cesium fluoride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 2-Phenyl-2-methyl-hexafluor-propan
  参考文献：
  名称：

  Fluoroolefins. II. Isomerization of .beta.-substituted perfluoroolefins. Kinetic vs. equilibrium control

  摘要：

  DOI：

  10.1021/jo01269a033

文献信息

• Cell preparation for treating cartilage tissue-related disorder
  申请人：NIPPON SHOKUBAI CO., LTD.

  公开号：US11213550B2

  公开（公告）日：2022-01-04

  To provide a spheroid-containing cell preparation exhibiting a high therapeutic effect for a cartilage tissue-related disorder as a treatment target. A prophylactic or therapeutic agent for a cartilage tissue-related disorder contains, as an effective ingredient, a spheroid including cultured mesenchymal stem cells.

  提供一种对软骨组织相关疾病具有较高治疗效果的含球形细胞制剂，作为治疗目标。 一种软骨组织相关疾病的预防或治疗剂，其有效成分是含有培养间充质干细胞的球形细胞。
• Functional material comprising fluorine-containing compound
  申请人：Koh Meiten

  公开号：US20070179263A1

  公开（公告）日：2007-08-02

  There is provided an ionic liquid type functional material which is useful for a lubricant, acid-removing agent, various ionic liquid materials, electrolyte for solar cell and actuator material. The ionic liquid type functional material contains an aromatic compound which has a fluorine-containing ether chain and is represented by the formula (1): [Ra-D m Ry  (1) wherein -D- is a fluoroether unit represented by the formula (1-1): O—R n or R—O n (1-1) in which R is at least one selected from divalent fluorine-containing alkylene groups having 1 to 5 carbon atoms in which at least one of hydrogen atoms is replaced by fluorine atom; n is an integer of from 1 to 20; when m is not less than 2, two or more of D may be the same or different; Ra is a monovalent organic group which has 1 to 20 carbon atoms and does not contain D; when m is not less than 2, two or more of Ra may be the same or different; m is an integer of from 1 to 4; Ry is a mono-, di-, tri- or tetra-valent organic group having 2 to 30 carbon atoms which has at least one selected from a basic functional group Y 1 and/or a salt Y 2 of the basic functional group and contains an aromatic ring structure, provided that a unit of —O—O— is not contained in the formulae (1) and (1-1).
• Photofunctional Laminated Article
  申请人：Ando Yoshito

  公开号：US20070218289A1

  公开（公告）日：2007-09-20

  There is provided a photofunctional laminated article being excellent in various photofunctionalities, particularly an intensity of light emission, light emitting efficiency and further fluorescence life and light amplifying property. The photofunctional laminated article comprises the transparent substrate (L0), the photofunctional layer (L1) comprising the fluorine-containing polymer (A) and the rare earth metal compound (B) and being formed on the substrate (L0) and the low refractive index layer (L2) formed on the photofunctional layer (L1), and when refractive indices of each layer are assumed to be n(L0), n(L1) and n(L2), the following equation: n(L0)≧n(L1)>n(L2) is satisfied.
• PHOTOACID GENERATOR COMPOUNDS AND COMPOSITIONS
  申请人：Ober Christopher K.

  公开号：US20090136868A1

  公开（公告）日：2009-05-28

  The invention provides various ionic and non-ionic photoacid generator compounds. Photoresist compositions that include the novel ionic and non-ionic photoacid generator compounds are also provided. The invention further provides methods of making and using the photoacid generator compounds and photoresist compositions disclosed herein. The compounds and compositions are useful as photoactive components in chemically amplified resist compositions for various microfabrication applications.
• CELL PREPARATION
  申请人：NIPPON SHOKUBAI CO., LTD.

  公开号：US20190307807A1

  公开（公告）日：2019-10-10

  To provide a spheroid-containing cell preparation exhibiting a high therapeutic effect for a cartilage tissue-related disorder as a treatment target. A prophylactic or therapeutic agent for a cartilage tissue-related disorder contains, as an effective ingredient, a spheroid including cultured mesenchymal stem cells.